Literature DB >> 15585516

Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis.

M M Löwik1, F A Hol, E J Steenbergen, J F M Wetzels, L P W J van den Heuvel.   

Abstract

BACKGROUND: The heterogeneity of mitochondrial cytopathies is characteristic for this group of disorders, which preferentially affect the muscle and nerve system. The A3243G transition in the tRNA(Leu(UUR)) gene has been associated with slowly progressive forms of focal segmental glomerulosclerosis (FSGS). Here we present a patient who developed a severe nephrotic syndrome during her first pregnancy, which persisted after delivery, and proved resistant to immunosuppressive therapy. A sister of our patient had developed diabetes mellitus. We analysed the DNA for the presence of the mitochondrial DNA (mtDNA) A3243G transition.
METHODS: DNA was isolated from peripheral blood leukocytes and urine sediments. Polymerase chain reaction was performed to amplify the mtDNA. Restriction enzyme analysis was used to detect the presence of the A3243G transition. Quantitative analysis of the A3243G mutation was done using the pyrosequencing technique.
RESULTS: Quantitative analysis revealed a proportion of mutated mtDNA of 30% in the leukocytes and 68% in the urine sediments of the proband. On further analysis, we also found the transition in the mother, the diabetic sister and the daughter of the proband.
CONCLUSION: MtDNA abnormalities can cause a steroid-resistant nephrotic syndrome, histologically characterized by FSGS. Physicians should be especially mindful of mitochondrial abnormalities when hearing loss, diabetes mellitus or neuromuscular disorders are present in the patient or family members.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585516     DOI: 10.1093/ndt/gfh546

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  31 in total

Review 1.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

2.  A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy.

Authors:  An I Jonckheere; Marije Hogeveen; Leo Nijtmans; Mariel van den Brand; Antoon Janssen; Heleen Diepstra; Frans van den Brandt; Bert van den Heuvel; Frans Hol; Tom Hofste; Livia Kapusta; U Dillmann; M Shamdeen; J Smeitink; J Smeitink; Richard Rodenburg
Journal:  BMJ Case Rep       Date:  2009-01-23

3.  Inheritance of the m.3243A>G mutation.

Authors:  Paul de Laat; Saskia Koene; Lambert P W J Vd Heuvel; Richard J T Rodenburg; Mirian C H Janssen; Jan A M Smeitink
Journal:  JIMD Rep       Date:  2012-07-06

4.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

Review 5.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

Review 6.  Mitochondrial disease in pregnancy: a systematic review.

Authors:  R E Say; R G Whittaker; H E Turnbull; R McFarland; R W Taylor; D M Turnbull
Journal:  Obstet Med       Date:  2011-06-23

7.  Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.

Authors:  Gabriela Casalena; Stefanie Krick; Ilse Daehn; Liping Yu; Wenjun Ju; Shaolin Shi; Su-yi Tsai; Vivette D'Agati; Maja Lindenmeyer; Clemens D Cohen; Detlef Schlondorff; Erwin P Bottinger
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-05

Review 8.  The renal biopsy in the genomic era.

Authors:  Helen Liapis; Joseph P Gaut
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

Review 9.  "Treasure your exceptions": recent advances in molecular genetics of glomerular disease.

Authors:  Andrzej Ciechanowicz; Andrzej Brodkiewicz; Agnieszka Bińczak-Kuleta; Miłosz Parczewski; Stanłisaw Czekalski
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

10.  Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood.

Authors:  Kristin E D'Aco; Megan Manno; Colleen Clarke; Jaya Ganesh; Kevin E C Meyers; Neal Sondheimer
Journal:  Pediatr Nephrol       Date:  2012-11-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.